Medical Properties Trust, Inc. (MPT) AI Stock Analysis

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception, the company has grown into an owner of hospital real estate with 378 facilities and approximately 38,000 licensed beds in nine countries across three continents as of March 31, 2026. MPT's financing structure facilitates acquisitions and recapitalizations, enabling hospital operators to unlock real estate equity to fund facility improvements, technology upgrades, and operational investments. Headquartered in Birmingham, Alabama, the REIT was incorporated in Maryland and employs 121 people.

Revenue decreased from $1.54B in FY2021 to $972.0M in FY2025, reflecting a 5-year revenue CAGR of -4.9%. After generating net income of $656.0M in FY2021 and $902.6M in FY2022, MPT recorded net losses of -$556.5M in FY2023, -$2.41B in FY2024, and -$277.0M in FY2025. Operating margin was 55.5% in FY2025, recovering from 9.3% in FY2023. Operating cash flow dropped from $811.7M in FY2021 to $230.8M in FY2025. Over the trailing twelve months ended June 30, 2026, revenue stood at $1.10B with a profit margin of -2.7% and quarterly revenue growth of 1.9% year-over-year.

As of June 30, 2026, Medical Properties Trust held $396.6M in cash and short-term investments compared to $9.70B in total debt, resulting in net debt of $9.31B. Shareholders' equity was $4.50B, with a debt-to-equity ratio of 2.16 and a current ratio of 0.31. In FY2025, the company generated $230.8M in operating cash flow and free cash flow. Capital expenditures were $222.1M, dividends paid totaled $193.3M, and share buybacks amounted to $23.4M.

MPT trades at a forward P/E of 6.7x, below the 23.5x median of its US-listed Real Estate peers. Its EV/EBITDA of 7.0x and price-to-sales of 1.6x also sit below the peer group medians of 14.7x and 3.7x, respectively. The stock trades at a price-to-book ratio of 0.5x. Over the past year, MPT's stock price fell 38.2%, trailing the S&P 500 return of 16.8%. Over a 5-year period, the stock declined 77.8% compared to an 83.0% gain for the index.

Medical Properties Trust pays a quarterly dividend with an annualized forward payout of $0.36 per share, representing a dividend yield of 11.96%. The company has paid dividends for 22 consecutive years, though the annualized 5-year dividend growth rate is -21.1%. In FY2025, dividends paid amounted to $193.3M, and the last ex-dividend date was September 10, 2026.

Wall Street analysts hold 3 Buy, 3 Hold, and 2 Sell ratings on MPT. The mean price target is $5.12, which represents a 70.3% premium over the last close of $3.01. For the current fiscal year ending December 31, 2026, consensus estimates project EPS of $0.10 on revenue of $1.04B. Over the last four quarters, the REIT beat EPS estimates twice. The next earnings release is scheduled for October 29, 2026.

This page is an AI-written research summary of Medical Properties Trust, Inc. (MPT). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: MPT income statement, MPT balance sheet, MPT key metrics, MPT analyst forecast, MPT chart. See the MPT stock overview for the latest quote and news.